AJANTPHARM.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages...

Stats
Dagens volum	225 095
Gjennomsnittsvolum	118 054
Markedsverdi	278.60B
EPS	INR0 ( 2024-04-26 )
Neste inntjeningsdato	( INR23.80 ) 2024-05-02
Last Dividend	INR15.00 ( 2023-08-04 )
Next Dividend	INR0 ( N/A )
P/E	38.06
ATR14	INR4.52 (0.20%)

Volum Korrelasjon

Lang: 0.54 (weak)

Kort: -0.73 (moderate negative)

Signal:(40.173) Neutral

Ajanta Pharma Limited Korrelasjon

10 Mest positive korrelasjoner
BHARATWIRE.NS	0.837
IZMO.NS	0.823
ASHIANA.NS	0.821
ASIANHOTNR.NS	0.805
AUROPHARMA.NS	0.801
GISOLUTION.NS	0.801

10 Mest negative korrelasjoner
STARTECK.NS	-0.829
SEYAIND.NS	-0.806

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ajanta Pharma Limited Korrelasjon - Valuta/Råvare

-0.38
( neutral )

-0.46
( neutral )

-0.82
( strong negative )

-0.29
( neutral )

0.42
( neutral )

0.62
( weak )

Ajanta Pharma Limited Økonomi

Annual	2022
Omsetning:	INR37.43B
Bruttogevinst:	INR26.92B (71.93 %)
EPS:	INR45.89

FY	2022
Omsetning:	INR37.43B
Bruttogevinst:	INR26.92B (71.93 %)
EPS:	INR45.89

FY	2022
Omsetning:	INR32.84B
Bruttogevinst:	INR23.97B (73.00 %)
EPS:	INR54.97

FY	2021
Omsetning:	INR28.47B
Bruttogevinst:	INR21.65B (76.03 %)
EPS:	INR50.06

Financial Reports:

No articles found.

Ajanta Pharma Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR7.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR15.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Ajanta Pharma Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.37 - low (12.11%) | Divividend Growth Potential Score: 5.23 - Stable (4.58%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.133	2002-12-17
Last Dividend	INR15.00	2023-08-04
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	INR73.42	--
Avg. Dividend % Per Year	0.57%	--
Score	2.22	--
Div. Sustainability Score	3.37
Div.Growth Potential Score	5.23
Div. Directional Score	4.30	--

Next Divdend (Est)
(2024-08-29)

INR16.81 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.22

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR6.00	0.78%
2019	INR8.67	1.10%
2020	INR6.33	0.97%
2021	INR6.33	0.58%
2022	INR7.00	0.47%
2023	INR15.00	1.24%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TATACONSUM.NS	Dividend Junior	2023-05-19	Annually	26	0.60%
NIPPOBATRY.NS	Dividend Junior	2023-09-20	Annually	23	1.06%
INDIANB.NS	Dividend Junior	2023-06-12	Annually	18	1.99%
CIPLA.NS	Dividend Junior	2023-07-20	Annually	28	0.41%
SANGHVIMOV.NS	Dividend Junior	2023-08-04	Sporadic	18	0.41%
M&MFIN.NS	Dividend Junior	2023-07-20	Annually	19	1.20%
GLOBUSSPR.NS	Dividend Junior	2023-07-14	Sporadic	15	0.36%
ASTEC.NS	No Dividend Player	2023-07-20	Annually	15	0.08%
TIPSINDLTD.NS	Dividend Junior	2023-08-03	Annually	17	0.03%
PEL.NS	Dividend Junior	2023-06-16	Annually	29	1.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.182	1.500	6.35	9.53	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.214	1.500	8.73	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	142.88	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	16.08	2.00	4.64	9.28	[0 - 30]
freeCashFlowPerShareTTM	16.08	2.00	1.958	3.92	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.742	1.000	0.974	0.974	[0.2 - 0.8]
operatingProfitMarginTTM	0.241	1.000	7.18	7.18	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.37

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	38.00	1.000	6.26	0	[1 - 100]
returnOnEquityTTM	0.214	2.50	9.18	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	16.08	2.00	4.64	3.92	[0 - 30]
dividendYielPercentageTTM	1.847	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	16.08	2.00	4.64	9.28	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.128	1.500	5.81	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0502	1.000	-1.246	0	[0.1 - 0.5]
Total Score				5.23

Ajanta Pharma Limited

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.

Sanntidsoppdatering for Ajanta Pharma Limited [AJANTPHARM.NS]

Upcoming Earnings Alert

Ajanta Pharma Limited Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)